1 / 3
文档名称:

糖肾康饮治疗早期糖尿病肾病80 例临床观察.doc

格式:doc   页数:3
下载后只包含 1 个 DOC 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

糖肾康饮治疗早期糖尿病肾病80 例临床观察.doc

上传人:799474576 2013/9/25 文件大小:0 KB

下载得到文件列表

糖肾康饮治疗早期糖尿病肾病80 例临床观察.doc

文档介绍

文档介绍:糖肾康饮治疗早期糖尿病肾病80例临床观察
施维敏1,马建2,程妍1,刘春燕2
(·哈尔滨150040)
摘要:目的:观察糖肾康饮对早期糖尿病肾病(DN)的临床疗效。方法:将80例DN患者随机分为对照组40例和治疗组40例,对照组在西医常规治疗基础上给予厄贝沙坦,治疗组在对照组治疗的基础上联合糖肾康饮。结果:治疗后治疗组的尿微量蛋白、C反应蛋白、血液流变学指标改善明显优于对照组(P均<)。%,%(P<)。结论:糖肾康饮对早期DN有较好的临床疗效。
关键词:糖肾康饮;糖尿病肾病;尿微量蛋白;血流变学
Clinical observation of 80 cases of early diabetic nephropathy treated with Tangshenkang drink
Shi Weimin 1,Majian2,Chengyan1,Liu Chunyan2
(1. Heilongjiang University of Chinese Medicine 2, No1 Hospital Affiliated to Heilongjiang University of Chinese Medicine, Harbin,150040)
Abstract: Objective: To observe Tangshenkang drink on early diabetic nephropathy (DN) of clinical efficacy. Methods: 80 patients with DN were randomly divided into control group of 40 patients and the treatment group of 40 patients in the control group on the basis of conventional therapy in Western medicine given irbesartan, the treatment group received treatment based on the joint Tangshenkang drink treatment. Results: After treatment, the urine protein, C-reactive protein, blood rheology improvement than the control group (P <). The total effective rate was % in the control group % (P <). Conclusion: Tangshenkang drink treatment of early DN have better clinical efficacy.
Keywords: Tangshenkang drink; diabetic nephropathy; urine protein; blood rheology
1引言
糖尿病肾病(DN)是糖尿病较常见的慢性微血管